Summit Trail Advisors LLC Purchases 738 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Summit Trail Advisors LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.7% in the third quarter, Holdings Channel.com reports. The firm owned 5,452 shares of the medical equipment provider’s stock after acquiring an additional 738 shares during the period. Summit Trail Advisors LLC’s holdings in Intuitive Surgical were worth $2,678,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Draper Asset Management LLC boosted its position in Intuitive Surgical by 39.1% during the 3rd quarter. Draper Asset Management LLC now owns 1,565 shares of the medical equipment provider’s stock valued at $769,000 after buying an additional 440 shares during the period. Alpha DNA Investment Management LLC bought a new stake in Intuitive Surgical during the 3rd quarter valued at approximately $719,000. Larson Financial Group LLC boosted its position in shares of Intuitive Surgical by 79.4% during the third quarter. Larson Financial Group LLC now owns 854 shares of the medical equipment provider’s stock valued at $420,000 after purchasing an additional 378 shares in the last quarter. Swedbank AB boosted its holdings in shares of Intuitive Surgical by 1.7% during the 3rd quarter. Swedbank AB now owns 180,043 shares of the medical equipment provider’s stock valued at $88,450,000 after buying an additional 2,944 shares in the last quarter. Finally, Algert Global LLC bought a new stake in Intuitive Surgical during the third quarter worth about $1,988,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent research reports. Royal Bank of Canada increased their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Robert W. Baird increased their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $524.61.

Intuitive Surgical Stock Down 0.5 %

NASDAQ:ISRG opened at $547.87 on Monday. The business’s 50-day simple moving average is $504.73 and its two-hundred day simple moving average is $464.13. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The stock has a market cap of $195.14 billion, a PE ratio of 88.08, a P/E/G ratio of 5.39 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now owns 821 shares in the company, valued at $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,539 shares of company stock worth $26,112,364 over the last quarter. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.